Search Results - "Chen, Eveline"
-
1
Measurement of endocrine activity (SET2,3) related to prognosis and prediction of benefit from dose-dense (DD) chemotherapy in estrogen receptor-positive (ER+) cancer: CALGB 9741 (Alliance)
Published in Journal of clinical oncology (01-06-2022)“…505 Background: We investigated the clinical utility of SET2,3, a novel biomarker designed to measure to endocrine sensitivity. SET2,3 measures…”
Get full text
Journal Article -
2
Analysis of the sensitivity to endocrine therapy (SET) assay in the PALLAS adjuvant trial of palbociclib in HR+/HER2- breast cancer (ABCSG-42/AFT-05/BIG-14-13)
Published in Journal of clinical oncology (01-06-2024)“…538 Background: The phase 3 PALLAS trial compared 2 years of the CDK4/6 inhibitor palbociclib with endocrine therapy of provider choice, versus endocrine…”
Get full text
Journal Article -
3
Technical Validity of a Customized Assay of Sensitivity to Endocrine Therapy Using Sections from Fixed Breast Cancer Tissue
Published in Clinical chemistry (Baltimore, Md.) (01-07-2020)“…Abstract Background We translated a multigene expression index to predict sensitivity to endocrine therapy for Stage II–III breast cancer (SET2,3) to…”
Get full text
Journal Article -
4
Pre‐analytical effects on whole transcriptome and targeted RNA sequencing analysis in cytology: The effects of prolonged time in storage of effusion specimens prior to preservation
Published in Cytopathology (Oxford) (01-11-2023)“…Abstract Objectives To investigate the pre‐analytics of the molecular testing of cytology specimens, we studied the effects of time in refrigerator storage…”
Get full text
Journal Article